Ken Arima

1.0k total citations
27 papers, 435 citations indexed

About

Ken Arima is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Ken Arima has authored 27 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Ken Arima's work include Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrest and Resuscitation (4 papers) and Acute Myocardial Infarction Research (4 papers). Ken Arima is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrest and Resuscitation (4 papers) and Acute Myocardial Infarction Research (4 papers). Ken Arima collaborates with scholars based in Japan. Ken Arima's co-authors include Katsuo Kanmatsuse, Ken Nagao, Ikuyoshi Watanabe, Kimio Kikushima, Nariyuki Hayashi, Yutaka Saito, Yousuke Katsuda, Tsutomu Imaizumi, Ken‐ichiro Sasaki and Teiji Okazaki and has published in prestigious journals such as Journal of the American College of Cardiology, Neurology and The American Journal of Cardiology.

In The Last Decade

Ken Arima

24 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Arima Japan 9 213 144 112 109 86 27 435
Tom Hurst United Kingdom 10 104 0.5× 139 1.0× 97 0.9× 66 0.6× 55 0.6× 24 385
Keywan Bayegan Austria 12 129 0.6× 111 0.8× 117 1.0× 35 0.3× 104 1.2× 21 416
Tomoaki Natsukawa Japan 10 167 0.8× 145 1.0× 126 1.1× 147 1.3× 20 0.2× 16 390
Benjamin L. Shou United States 10 107 0.5× 152 1.1× 68 0.6× 149 1.4× 14 0.2× 50 316
Timothy S. Hall United States 12 41 0.2× 304 2.1× 61 0.5× 80 0.7× 46 0.5× 31 497
Xing Hao China 9 113 0.5× 143 1.0× 90 0.8× 188 1.7× 17 0.2× 32 314
Takayuki Kosuge Japan 12 136 0.6× 207 1.4× 104 0.9× 44 0.4× 12 0.1× 53 392
Michael C. Mauney United States 17 90 0.4× 395 2.7× 260 2.3× 91 0.8× 70 0.8× 24 770
Benjamín Erranz Chile 11 154 0.7× 77 0.5× 28 0.3× 112 1.0× 82 1.0× 22 442
Thomas Prendergast United States 15 102 0.5× 472 3.3× 267 2.4× 276 2.5× 20 0.2× 20 715

Countries citing papers authored by Ken Arima

Since Specialization
Citations

This map shows the geographic impact of Ken Arima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Arima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Arima more than expected).

Fields of papers citing papers by Ken Arima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Arima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Arima. The network helps show where Ken Arima may publish in the future.

Co-authorship network of co-authors of Ken Arima

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Arima. A scholar is included among the top collaborators of Ken Arima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Arima. Ken Arima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukamachi, Daisuke, Nobuhiro Murata, Naoya Matsumoto, et al.. (2024). Clinical Significance of Early Computed Tomography Scan on Thrombus Regression Rate in Acute Pulmonary Embolism: Insights from the SAKURA PE/DVT REGISTRY. Journal of Atherosclerosis and Thrombosis. 32(6). 688–702.
3.
4.
Fukamachi, Daisuke, Yasuo Okumura, Naoya Matsumoto, et al.. (2022). Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease. Journal of Interventional Cardiology. 2022. 1–10. 6 indexed citations
5.
Fukamachi, Daisuke, Yasuo Okumura, Naoya Matsumoto, et al.. (2020). Design and Rational for a Prospective Randomized Study of Safety Outcomes Treated with Edoxaban in Patients with Stable Coronary Artery Disease and Atrial Fibrillation (PRAEDO AF Study). Journal of Clinical Trials. 10(2). 1–5. 1 indexed citations
7.
Nagashima, Koichi, Yasuo Okumura, Katsuaki Yokoyama, et al.. (2019). Comparison of continuous 24-h and 14-day monitoring for detection of otherwise unknown atrial fibrillation: a registry to identify Japanese concealed atrial fibrillation (REAL-AF)-based study. Heart and Vessels. 35(5). 689–698. 6 indexed citations
8.
Okumura, Yasuo, Katsuaki Yokoyama, Naoya Matsumoto, et al.. (2018). Patient Satisfaction with Direct Oral Anticoagulants and Warfarin. International Heart Journal. 59(6). 1266–1274. 25 indexed citations
9.
Imori, Yoichi, Takeshi Akasaka, Tomoki Ochiai, et al.. (2013). Co-Existence of Carotid Artery Disease, Renal Artery Stenosis, and Lower Extremity Peripheral Arterial Disease in Patients With Coronary Artery Disease. The American Journal of Cardiology. 113(1). 30–35. 40 indexed citations
10.
Yamanaka, Futoshi, Kazuki Tobita, Kazuya Sugitatsu, et al.. (2012). AS-099: Is 320-Slice Computed Tomography Coronary Angiography Really Useful for Symptomatic Patients?. The American Journal of Cardiology. 109(7). S125–S125. 1 indexed citations
11.
Arima, Ken, Sho‐ichi Yamagishi, Takanori Matsui, et al.. (2010). Inhibition of Pigment Epithelium-Derived Factor (PEDF) Augments Vascular Endothelial Growth Factor (VEGF)-Induced Recovery of Limb Perfusion after Ischemia in Klotho Mouse. Letters in Drug Design & Discovery. 7(7). 541–545. 1 indexed citations
12.
Saitoh, Yuji, Megumu Ogawa, Yutaka Naito, et al.. (2009). DISCORDANT CLINICOPATHOLOGIC PHENOTYPES IN A JAPANESE KINDRED OF FATAL FAMILIAL INSOMNIA. Neurology. 74(1). 86–89. 10 indexed citations
13.
Katsuda, Yousuke, Hisashi Kai, Yutaka Saito, et al.. (2007). Vitamin C Reversed Malfunction of Peripheral Blood-Derived Mononuclear Cells in Smokers Through Antioxidant Properties. Circulation Journal. 72(4). 654–659. 9 indexed citations
14.
Liebeskind, David S., et al.. (2005). Piclozotan (SUN N4057), a Novel 5HT1A Receptor Agonist, Is Well Tolerated in Patients with Acute Stroke. Annals of Emergency Medicine. 46(3). 106–106. 5 indexed citations
16.
Nagao, Ken, Nariyuki Hayashi, Katsuo Kanmatsuse, et al.. (2000). Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. Journal of the American College of Cardiology. 36(3). 776–783. 211 indexed citations
18.
Matsuura, Hiroshi, M Sakurai, & Ken Arima. (1999). [Clinical experience of extracorporeal shock wave lithotripsy for elderly patients with upper urinary stones].. PubMed. 45(6). 393–6. 2 indexed citations
19.
Nagao, Ken, et al.. (1998). Angiographic Study of Mutant Tissue-Type Plasminogen Activator Versus Urokinase for Acute Myocardial Infarction. Japanese Circulation Journal. 62(2). 111–114. 5 indexed citations
20.
Kato, Takahiro A., et al.. (1993). [Dietary control for out-patients in urinary stone clinic].. PubMed. 39(7). 593–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026